
-
Digital Biomarkers – Frontiers for personalised medicine
We are entering a new age of medicine. Every one of us is different. Not just in the way we look, but also in the way we behave. These differences in behaviour have profound impacts on our health, but also on how we respond to illness and treatments. Every patient that walks through the doors… Read more
-
Do we still need animals in the lab?
The pharmaceutical and biotechnology industries are heavily regulated. Governmental organisations such as the Medicines and Health Regulatory Authority (MHRA) in the UK, the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) in the US impose rules on the drug development process. Moving a drug through the development pipeline at present requires preclinical… Read more
-
Cord Blood Banking – Are we discarding something valuable?
In the United States, cord blood banking is a common practice. It involves the cryopreservation of cord blood after birth. In other words, after a baby is born cord blood is drawn from the umbilical cord, processed and stored in liquid nitrogen for future clinical application. In the UK, there are still large parts of… Read more
-
Alzheimer’s Disease – Are you in control of your diet?
One of the most discussed topics in the media over the last 12 months is Alzheimer’s Disease and Dementia. With more than 850,000 people suffering from dementia in the UK and over 52% of the UK public aware of someone in their circles who has dementia, it is clear that this particular family of conditions… Read more
-
Drug Discovery – Is innovation sustainable?
The pharmaceutical industry is often regarded as an industry filled with unaccountable large corporations whose sole purpose is making money. What drives this perception? Why is there a level of distrust towards these companies and can this attitude change? How do drugs get from the lab to the shelves of the pharmacy? Why are drugs… Read more